Vaccination-challenge interval markedly influences protection provided by Rispens CVI988 vaccine against very virulent Marek's disease virus challenge

References

• Afonso, C.L., Tulman, E.R., Lu, Z., Zsak, L., Rock, D.L. & Kutish, G.F. (2001). The genome of turkey herpesvirus. Journal of Virology, 75, 971–978. 10.1128/JVI.75.2.971-978.2001
   PubMed Web of Science ®Google Scholar
• Baaten, B.J.G., Butter, C. & Davison, T. (2004). Study of host-pathogen interactions to identify sustainable vaccine strategies to Marek's disease. Veterinary Immunology and Immunopathology, 100, 165–177. 10.1016/j.vetimm.2004.04.009
   PubMed Web of Science ®Google Scholar
• Baigent, S.J., Smith, L.P., Currie, R.J.W & Nair, V.K. (2007). Correlation of Marek's disease herpesvirus vaccine virus genome load in feather tips with protection, using an experimental challenge model. Avian Pathology, 36, 467–474. 10.1080/03079450701639319
   PubMed Web of Science ®Google Scholar
• Bulow, V.V., Landgraf, H. & Vielitz, E. (1976). Differentiation between antibodies against turkey herpesvirus and Marek's disease virus in field sera. Zentralblatt für Veterinarmedizin Reihe B-Journal of Veterinary Medicine Series B-Infectious Diseases Immunology Food Hygiene Veterinary Public Health, 23, 391–402. 10.1111/j.1439-0450.1976.tb01620.x
   PubMedGoogle Scholar
• Burmester, B.R., Purchase, H.G. & Okazaki, W. (1972). Long-term experiences with the herpesvirus of turkeys (HVT) as a vaccine against Marek's disease. Progress in Immunobiological Standards, 5, 132–138.
   Google Scholar
• Calnek, B.W., Schat, K.A., Peckham, M.C. & Fabricant, J. (1983). Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease. Avian Diseases, 27, 844–849. 10.2307/1590330
   PubMed Web of Science ®Google Scholar
• Chubb, R.C. & Churchill, A.E. (1969). Effect of maternal antibody on Marek's disease. The Veterinary Record, 85, 303–305. 10.1136/vr.85.11.303
   PubMed Web of Science ®Google Scholar
• Churchill, A.E., Payne, L.N. & Chubb, R.C. (1969). Immunization against Marek's disease using a live attenuated virus. Nature, 221, 744–747. 10.1038/221744a0
   PubMed Web of Science ®Google Scholar
• Cole, R.K. (1968). Studies on genetic resistance to Marek's disease. Avian Diseases, 12, 9–28. 10.2307/1588081
   PubMed Web of Science ®Google Scholar
• Gimeno, I.M., Cortes, A.L. & Silva, R.F. (2008). Load of challenge Marek's disease virus DNA in blood as a criterion for early diagnosis of Marek's disease tumors. Avian Diseases, 52, 203–208. 10.1637/8089-081407-Reg.1
   PubMed Web of Science ®Google Scholar
• Ianconescu, M., Purchase, H.G., Okazaki, W. & Burmester, B.R. (1971). Influence of natural exposure on response to subsequent challenge with virulent Marek's disease. Avian Diseases, 15, 745–752. 10.2307/1588863
   PubMed Web of Science ®Google Scholar
• Islam, A. & Walkden-Brown, S.W. (2007). Quantitative profiling of the shedding rate of the three Marek's disease virus (MDV) serotypes reveals that challenge with virulent MDV markedly increases shedding of vaccinal viruses. Journal of General Virology, 88, 2121–2128. 10.1099/vir.0.82969-0
   PubMed Web of Science ®Google Scholar
• Islam, A.F.M.F., Walkden-Brown, S.W., Groves, P.J. & Underwood, G.J. (2007). Effects of vaccine dose, virus challenge dose and interval from vaccination to challenge on protection of broiler chickens against Marek's disease virus challenge. Australian Veterinary Journal, 85, 348–355. 10.1111/j.1751-0813.2007.00195.x
   PubMed Web of Science ®Google Scholar
• Islam, A.F.M.F., Walkden-Brown, S.W., Groves, P.J. & Underwood, G.J. (2007). Effects of HVT vaccine dose, Marek's disease virus (MDV) challenge dose and vaccination to challenge interval on protection against MDV challenge in broiler chickens. Australian Veterinary Journal, 85, 348–355. 10.1111/j.1751-0813.2007.00195.x
   PubMed Web of Science ®Google Scholar
• Islam, A.F.M.F., Walkden-Brown, S.W., Groves, P.J. & Underwood, G.J. (2008). Kinetics of Marek's disease virus (MDV) infection in broiler chickens 1: Effect of varying vaccination to challenge interval on vaccinal protection and load of MDV and herpesvirus of turkey in the spleen and feather dander over time. Avian Pathology, 37, 225–235. 10.1080/03079450701802230
   PubMed Web of Science ®Google Scholar
• Islam, A.F.M.F., Walkden-Brown, S.W., Islam, A., Underwood, G.J. & Groves, P.J. (2006). Relationship between Marek's disease virus load in PBL at various stages of infection and clinical Marek's disease in broiler chickens. Avian Pathology, 35, 42–48. 10.1080/03079450500465734
   PubMed Web of Science ®Google Scholar
• Jackson, C.A.W. (2000). Lessons from 30 years of Marek's disease control in Australia for 2000 and beyond. Proceedings of Australian Poultry Science Symposium, 12, 186–189.
   Google Scholar
• Maas, H.J.L., Borm, F. & van Kieft, G. (1982). The prevention of Marek's disease in Holland by vaccination with cell-associated vaccines—results of field trials and routine vaccinations between 1970–1980. World's Poultry Science Journal 38, 163–175. 10.1079/WPS19820012
   Web of Science ®Google Scholar
• Morimura, T., Ohashi, K., Sugimoto, C. & Onuma, M. (1998). Pathogenesis of Marek's disease (MD) and possible mechanisms of immunity induced by MD vaccine. Journal of Veterinary Medical Science, 60, 1–8. 10.1292/jvms.60.1
   PubMed Web of Science ®Google Scholar
• Okazaki, W., Purchase, H.G. & Burmester, B.R. (1970). Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Diseases, 14, 413–429. 10.2307/1588488
   PubMed Web of Science ®Google Scholar
• Osterrieder, K. & Vautherot, J.-F. (2004). The genome content of Marek's disease-like viruses. In F. Davison & V. Nair (Eds.). Marek's Disease. An Evolving Problem (pp.17–31). Amsterdam: Elsevier.
   Google Scholar
• Purchase, H.G. & Okazaki, W. (1971). Effect of vaccination with herpesvirus of turkeys (HVT) on horizontal spread of Marek's disease herpesvirus. Avian Diseases, 15, 391–397. 10.2307/1588710
   PubMed Web of Science ®Google Scholar
• Renz, K.G. (2008). In vitro and in vivo characterization of selected Australian isolates of Marek's disease virus. Doctor of Philosophy Thesis, University of New England, Armidale.
   Google Scholar
• Renz, K.G., Cheetham, B.F. & Walkden-Brown, S.W. (2013). Differentiation between pathogenic serotype 1 isolates of Marek's disease virus and the Rispens CVI988 vaccine in Australia using real-time PCR and high resolution melt curve analysis. Journal of Virological Methods, 187, 144–152. 10.1016/j.jviromet.2012.09.018
   PubMed Web of Science ®Google Scholar
• Renz, K.G., Cooke, J., Clarke, N., Cheetham, B.F., Hussain, Z., Islam, A.F.M.F., Tannock, G.A. & Walkden-Brown, S.W. (2012). Pathotyping of Australian isolates of Marek's disease virus and association of pathogenicity with meq gene polymorphism. Avian Pathology, 41, 161–176. 10.1080/03079457.2012.656077
   PubMed Web of Science ®Google Scholar
• Rispens, B.H., van Vloten, H., Mastenbroek, N., Maas, H.J., & Schat, K.A. (1972). Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Diseases, 16, 108–125. 10.2307/1588905
   PubMed Web of Science ®Google Scholar
• Schat, K.A. & Calnek, B.W. (1978). Characterization of an apparently nononcogenic Marek's disease virus. Journal of the National Cancer Institute, 60, 1075–1082.
   PubMed Web of Science ®Google Scholar
• Schat, K.A. & Nair, V. (2008). Marek's disease. In Y.M. Saif, A.M. Fadly, J.R. Glisson, L.R. McDougald, L.K. Nolan & D.E. Swayne (Eds.), Diseases of Poultry 12th edn (pp. 452–514). Ames, USA: Blackwell Publising Professional.
   Google Scholar
• Vielitz, E. & Landgraf, H. (1971). Impfversuche gegen Marek'sche Krankheit unter verwendung von attenuiertem Marek-Herpes-Virus und Puten-herpes-virus. Deutsche Tierartzliche Wochenschrift, 78, 617–623.
   PubMedGoogle Scholar
• Walkden-Brown, S.W., Islam, A., Islam, A.F.M.F., Burgess, S.C., Groves, P. & Cooke, J. (2013). Pathotyping of Australian isolates of Marek's disease virus in commercial broiler chickens vaccinated with HVT or bivalent (HVT/SB1) vaccine and association with viral load in spleen and feather dander. Australian Veterinary Journal.
   Google Scholar
• Witter, R.L. (1996). Evolution of virulence of Marek's disease virus: Evidence for a novel pathotype. Current Research on Marek's Disease, 86–91.
   Google Scholar
• Witter, R.L. (1997). Increased virulence of Marek's disease virus field isolates. Avian Diseases, 41, 149–163. 10.2307/1592455
   PubMed Web of Science ®Google Scholar
• Witter, R.L. (1998). The changing landscape of Marek's disease. Avian Pathology, 27, S46–S53. 10.2307/1592455
   Web of Science ®Google Scholar
• Witter, R.L. (1982). Protection by attenuated and polyvalent vaccines against highly virulent strains of Marek's disease virus. Avian Pathology, 11, 49–62. 10.1080/03079458208436081
   PubMed Web of Science ®Google Scholar
• Witter, R.L., Lee, L.F. & Fadly, A.M. (1995). Characteristics of CV1988/Rispens and R2/23, 2 prototype vaccine strains of serotype-1 Marek's disease virus. Avian Diseases, 39, 269–284. 10.2307/1591868
   PubMed Web of Science ®Google Scholar
• Witter, R.L., Sharma, J.M., Lee, L.F., Opitz, H.M. & Henry, C.W. (1984). Field trials to test the efficacy of polyvalent Marek's disease vaccines in broilers. Avian Diseases, 28, 44–60. 10.2307/1590127
   PubMed Web of Science ®Google Scholar
• Zelnik, V., Harlin, O., Fehler, F., Kaspers, B., Gobel, T.W., Nair, V.K. & Osterrieder, N. (2004). An enzyme-linked immunosorbent assay (ELISA) for detection of Marek's disease virus-specific antibodies and its application in an experimental vaccine trial. Journal of Veterinary Medicine Series B-Infectious Diseases and Veterinary Public Health, 51, 61–67. 10.1111/j.1439-0450.2004.00728.x
   Web of Science ®Google Scholar